Future of drugs-Diabetes_LIK-066

Drug Name
(S)-Pyrrolidine-2-carboxylic acid compound with (2S,3R,4R,5S,6R)-2-(3-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-4-ethylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (2:1)
Structure
 
Drug Code
LIK-066
Synonym
-
Molecular Formula
C23H28O7.2 C6 H11NO
Innovator
Novartis
Condition
Type-2 diabetes mellitus
Mechanism of Action
Sodium-glucose transporter 2 inhibitor
Clinical Phase
II in USA

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati